- Home
- Our innovation
- Research & development
- Discovery, product development & supply
Discovery, product development & supply
Discovery, Product Development & Supply (DPDS) is the molecular invention, development, and delivery engine within Johnson & Johnson. Our team targets the hardest-to-treat diseases, combining the expertise of our multi-disciplinary scientists with external innovators to unlock the most promising science and turn complex therapeutic concepts into transformational therapies for patients.
Driven to deliver
Our global team of approximately 4,000 drug hunters, drug developers, and clinical supply experts are critical to reimagining the entire R&D process from inception to delivery of medicines to patients. Driven by innate curiosity, they translate the best ideas into differentiated therapies and innovative manufacturing capabilities to have a profound impact on human health.
With our cross-functional approach to innovation, deep expertise, and global footprint, we aim to invent and develop transformational therapies for patients by exploring new pathways and embracing a source-agnostic, multi-modality treatment approach.”
Richard (Rich) Tillyer, Ph.D.
Global Head, Discovery, Product Development & Supply
Our discovery, product development & supply process
Our discovery, product development & supply process
Our discovery, product development & supply process
Mastering discovery and development
We are modality-agnostic, seeking to understand diseases at a molecular level and intervene most effectively in their biological pathways using small molecule and protein modalities, cell and gene therapies, and RNA therapeutics. Our lead-generation engine is comprised of powerful screening platforms and unique artificial intelligence tools that help us identify targets faster and more efficiently than ever before. We collaborate with world-class scientific innovators to create novel products that neither organization could achieve alone.